SciRhom
PrivateLast Round
Series A
Jul 9, 2024
Total Funding Raised
$105.28M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SciRhom is a biotechnology company that develops first-in-class therapeutic antibodies targeting iRhom2 to treat autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SciRhom Comparables
Compare SciRhom with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Johnson & Johnson | 69% | |
| AstraZeneca | 66% | |
| Shattuck Labs | 63% |
SciRhom Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 9, 2024 | ||||
| Seed | Nov 30, 2021 | ||||
| Seed | Jan 12, 2021 | ||||
| Seed | Nov 5, 2019 |
Key People
Founding team and executive leadership
SciRhom Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIG Capital | Series A |
| Andera Partners | Series A |
| MIG AG | Series A |
| Ventura Ace | Seed |
| Hadean Ventures | Series A |
| Wellington Partners | Series A |
| Bayern Kapital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 828% MoM, from 67 to 622.
- Apr 4, 2026
Monthly visitors grew 92% MoM.
SciRhom Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SciRhom's valuation, stock price, and market status.
Is SciRhom a public or private company?
SciRhom is a private company.
What is the current stock price of SciRhom?
SciRhom is a private company with no public stock price. No recent secondary market data is available.
How much is SciRhom worth (valuation)?
Valuation information for SciRhom is not publicly available.
Can I buy SciRhom stock?
SciRhom shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SciRhom's last funding round?
SciRhom's most recent funding round was Series A on July 9, 2024.
Who are the main investors in SciRhom?
Key investors in SciRhom include MIG Capital, Andera Partners, Hadean Ventures, Wellington Partners, Kurma Partners.
Will SciRhom IPO soon?
No public IPO plans have been announced for SciRhom.
How can I track SciRhom secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SciRhom's secondary market activity and sign up for updates.